● Intended Use

The kit is intended for in vitro qualitatively detection of Influenza A virus (Flu A), Influenza B virus (Flu B) and Respiratory syncytial virus (RSV) antigen in oropharyngeal or nasopharyngeal swabs. It can be used to assist in the diagnosis of respiratory infectious diseases. The detection results are only for clinical reference, and aids in the diagnosis of respiratory infection if used in conjunction with other clinical and epidemiological information.

***For professional use

● Features

RAPID: 15 min to read test result

SAMPLE: no instrument needed

EFFICIENCY: ONE step to get visual interpretation

Multiplex: One detection card reflects 3 pathogens results

● Operation process

● Respiratory Tract Infections (RTIs)

Respiratory tract infections are infections of parts of the body involved in breathing, such as the sinuses, throat, airways or lungs. Due to the differences of infections organism, RTIs divided into upper and lower respiratory tract, symptoms include cold, bronchiolitis, pneumonia, croup, otitis media. Viruses are the most common cause of RTIs, such as influenza viruses, respiratory syncytial virus, chlamydia pneumoniae, human parainfluenza virus, and coronavirus.

Lower respiratory tract infections (LRTI) remained the world’s most deadly communicable disease. WHO (2019) reported that LRTI ranked as the 4th leading cause of death globally and 4th leading cause of disability-adjusted life years. Besides, Acute Respiratory Tract Infection (ARTI) is one of the most common infectious diseases and its incidence ranked as 1st among acute infectious diseases.

It is important to detect infectious pathogens for the precise treatment. ZBI’s respiratory antigen test kit is a prior choice for early, rapid, and multiplex detection. 

ZBI-respiratory antigen test kit.pdf